Antibiotic resistance in pulmonary infections: mechanisms and epidemiology

Oliwia Makarewicz, Mareike Klinger-Strobel, Ralf Ehricht, Michael Kresken, Mathias W. Pletz

Source: Eur Respir Monogr 2017; 75: 21-43
Disease area: Respiratory infections

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Oliwia Makarewicz, Mareike Klinger-Strobel, Ralf Ehricht, Michael Kresken, Mathias W. Pletz. Antibiotic resistance in pulmonary infections: mechanisms and epidemiology. Eur Respir Monogr 2017; 75: 21-43

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Epidemiological impact of antibiotic use/misuse in the community
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=165
Year: 2004

Non-pharmacological factors for the emergence of drug resistance in patients of pulmonary tuberculosis: An Indian overview
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012

Antibiotic resistance and nosocomial pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 641s
Year: 2005

Antibiotic resistance and clinical outcomes: the CAPNETZ experience
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006



Basics of pulmonary and extrapulmonary TB epidemiology - drug resistance in Europe
Source: Annual Congress 2003 - PG22 - Tuberculosis epidemiology and control
Year: 2003

Antibiotic management and resistance
Source: Eur Respir Monogr 2018; 81: 312-330
Year: 2018


Antibiotic resistance in respiratory infections: challenges and actions for the upcoming decade
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021


The etiology and antimicrobial drugs resistance of microorganisms in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 2s
Year: 2006

Antimicrobial resistance in respiratory diseases
Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship
Year: 2019


Characteristics of the cases with primary multidrug resistance pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

Empiric antibiotic treatment and pathogens resistance in respiratory tract infections; a prospective epidemiological survey
Source: Eur Respir J 2003; 22: Suppl. 45, 335s
Year: 2003

Infective agents and their antibiotic susceptibility in patients with respiratory infections
Source: Eur Respir J 2005; 26: Suppl. 49, 639s
Year: 2005

Perspectives on antibiotic treatment of NTM pulmonary disease
Source: Eur Respir Monogr 2017; 75: 245-252
Year: 2017


Impact of antibiotic consumption in the evolution of respiratory pseudomonas antibiotic resistance
Source: Eur Respir J 2006; 28: Suppl. 50, 787s
Year: 2006

Bacteria, antibiotics and COPD
Source: Eur Respir J 2001; 17: 995-1007
Year: 2001



Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines
Source: Eur Respir J 2011; 37: 112-118
Year: 2011



Future antibiotics and current practices for treating respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=255
Year: 2004

Analysis of antibiotic resistance and enterococcal infections of low respiratory infection on patients in hospital
Source: Eur Respir J 2003; 22: Suppl. 45, 450s
Year: 2003

Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?
Source: Eur Respir J 2010; 35: 606-613
Year: 2010



Antibiotics for pulmonary infections: an overview
Source: Eur Respir Monogr 2017; 75: 1-20
Year: 2017